In the news
2 MIN
February 27, 2023
.jpg)
Curebase appeared in Y Combinator's 2023 list of top private companies where we are noted for our end-to-end clinical trial execution built on cutting-edge software. Y Combinator listed over 4,000 private companies in their 2023 list with Curebase placed in the top 6%.
See the full list of Y Combinator Private Companies here.
Curebase appeared in Y Combinator's 2023 list of top private companies where we are noted for our end-to-end clinical trial execution built on cutting-edge software. Y Combinator listed over 4,000 private companies in their 2023 list with Curebase placed in the top 6%.
See the full list of Y Combinator Private Companies here.
Expanding patient access by reaching geographies untapped by traditional clinical research sites.
.jpg)
Curebase's Whitney Stewart and DTA's Megan Coder discuss the joint whitepaper recently released by Curebase and DTA and what this means for the future of the DTx industry on the Empowered Patient Podcast
Blue Note Therapeutics and Curebase collaboration on home-based DTx clinical trial.
.jpg)
Sites venturing into the growing field of digital therapeutics (DTx) need the appropriate infrastructure, tech know-how and adaptability, while sponsors need to be willing to offer training/support, iron out hurdles that come with remote components and simplify these trials whenever possible, a clinical research expert advises.
In this episode we discuss evidence standards for digital therapeutics and the recent Digital Therapeutics Alliance publication “Setting the Stage for a Fit-For-Purpose DTx Evidentiary Standard”.
Welcome to DTx Equals, the show where thought leaders in digital therapeutics put a stake in the ground about what makes DTx, DTx.
Learn about the joint whitepaper put forth by the DTA and Curebase on evidentiary standards in DTx and what future implications for the industry are.
.jpg)
DCT platform company places in top 6% of private companies; recognized for end-to-end clinical trial execution built on cutting-edge software
Passionate Pioneers with Mike Biselli
.jpg)
Whitney Stewart shared her predictions for 2023
Curebase appeared in Y Combinator's 2023 list of top private companies where we are noted for our end-to-end clinical trial execution built on cutting-edge software.
PharmaShots interviews Whitney Stewart
Med Ad News talked to Jane Myles, vice president of clinical trial innovation at Curebase, about improving clinical trials and patient experience.
Host Tom Foley invites Whitney Stewart, Director of Clinical Project Management at Curebase & Megan Coder, Founder, Chief Policy Officer at DTxAlliance.
Curebase is a one-stop shop for running your digital therapeutics trial from start to finish
DCT platform company expands business, adds executive talent
Start-up trials achieved in eight to 12 weeks, a fraction of typical timeframe
.jpg)
Publication provides a foundational set of expectations outlining the necessary clinical evidence to enable appropriate and efficient assessment reflective of the unique nature and innovation cycles of DTx products
Curebase partners with Redenlab to deliver high-quality patient data
A new approach allows patients to participate in clinical trials from home and with community physicians
.jpg)
Jane Myles, Vice President, Clinical Trial Innovation at Curebase, discusses her current role, what led her there, and challenges their clients face with DCTs.
Curebase to Leverage BEKHealth's Integrated Clinical Research Platform to More Easily Find and recruit Decentralized Trial Participants, Expand into Oncology and New Therapeutic Areas
Companies like Pfizer, Novartis, Sanofi and BMS are diving into the world of digital therapeutics while recognizing the limitations of the young field.
.jpg)
An online mental health provider and a provider of decentralized clinical research teamed up to build an app that may offer a digital health solution to address provider shortages in mental healthcare.
It's important to be creative when overcoming obstacles to access to wider improvements in trial design and participation, says Jane Myles, VP of clinical trial innovation at Curebase.
For companies that have spent years developing interactive technologies to help treat disease, the tricky question inevitably comes: How far are you willing to go to prove it works?
Curebase signed a three-year clinical trial with Meru Health
Curebase and Meru Health announce partnership on three-year clinical trial.
Curebase welcomes Matt Lanier as VP of Engineering
.jpg)
Y Combinator released its list of top companies for 2022, this year Curebase was featured in the list of Top Private Companies.
Curebase welcomes Sean Lynch as Vp of Clinical Operations
.jpg)
One of the first attorneys to specialize in DCTs, Laura Podolsky, joins Curebase as General Counsel.
.jpg)
Alan Sun brings his passion for finding solutions that improve patient outcomes as Curebase's new VP of Product
.jpg)
User-friendly clinical trial solution design to increase participant engagement
.jpg)
Andi Seymour brings over 15 years of progressive and hands-on experience to Curebase as the newly appointed VP of People.
Curebase and Portamedic partner to collect patient samples and other tests from participating DCT trial patients' homes throughout the U.S
.jpg)
Scott Garcia brings 15+ years of experience scaling high-growth companies to Curebase as the new VP of Finance
Curebase and Flow Neuroscience investigate a digital therapeutic for reducing depressive symptoms.
Lars-Olof "Lollo" Erkisson, Head of Clinical Development at Infant Therapeutics AB, brings cross-continental clinical operations expertise to Curebase Advisory Board
Curebase closes $40M Series B led by Industry Ventures, with strategic investment by Gilead Sciences
Curebase recognized by Fast Company's 2022 World Changing Ideas Awards for decentralized, patient-centric trial model
Part 2 of Note to File Podcast with Brad Hightower featuring Jane Myles, VP of Clinical Trial Innovation at Curebase
Curebase and Vicore Pharma partner on IPF mental health digital therapeutic study
Curebase featured as decentralized clinical provider optimizing digital processes for patient safety and scientific advancement
Jane Myles, VP of Innovation at Curebase, discusses how DCTs play a role in improving health equity
Jane Myles appears on Note to File Podcast with Bradley Hightower to discuss all things DCT
.jpg)
Curebase hires its 100th teammate within six months of raising Series A financing
Curebase and Blue Note Therapeutics partner on a fully virtual study comparing effectiveness of two PDTs on mental and physical health of cancer patients recently/currently undergoing treatment
Curebase launching DCT study in Italy and France with a lab from the University of Côte d'Azur to improve the quality of life for elderly people
Curebase welcomes Dr. Amir Lahav, leading digital health innovator, and Dr. Aaron Kamauu, leading real-world data expert, to new Advisory Board
Curebase will work closely with Society for Clinical Research Sites to advance trial site engagement and sustainability
Continuous developments in digital health innovations has led to the expansions of the Digital therapeutics dtx clinical trial space
Tom Lemberg, founder and CEO of Curebase, talks all things BYOP (Bring Your Own Physician) on Empowered Patient Podcast
Healthcare IT Today features predictions from Tom Lemberg, founder and CEO of Curebase, on diversity in clinical research
Curebase founder and CEO, Tom Lemberg, discusses the future of patient-centric decentralized clinical trials, including the Bring Your Own Physician (BYOP) model
Curebase and Persephone, collaborating with Janssen Research & Development, announce study to develop prevention strategies and treatment options for colorectal cancer (CRC) focusing on patient diversity
Curebase Earns Top 100 on Built In's Best Remote-First Companies to Work for in 2022
Decentralized clinical trial company brings expertise in remote studies to large industry group devoted to improving trial quality
Curebase serves as technology and decentralized trial execution partner for MetaMe Health's digital therapeutic dtx
Curebase recognized for achievements in Clinical Trials Tech
Curebase CEO offers expert insight into the dawn of dynamic clinical trial designs
Founder and CEO of Curebase receives Forbes 30 Under 30 prestigious honor for leading positive, global change in healthcare
Edesa Biotech uses Curebase's eClinical platform for enhanced telemedicine that allows providers to view, measure, and record patient symptoms via the built-in application
Decentralized clinical trials leverages Curebase eclinical software platform, Veterans' advocacy groups
Curebase and Checkable Medical launch first-ever at-home strep test decentralized clinical trial
Curebase and DTA partner to develop a joint white paper to provide clinical trial regulatory guidance and best practices for DTx clinical evidence generation
Curebase's decentralized clinical trial approach helps secure FDA Emergency Use Authorization for InBios' new COVID-19 IgG Antibody Rapid Test
Katri Langel, international IT and clinical research expert, joins Curebase as Senior Director of Program Development for Europe
Curebase names clinical trials veteran, Wayne Bowden, as Vice President of Business Development to lead new growth and expansion efforts
AppliedVR will test its virtual-reality-based digital therapeutics dtx across five studies using the decentralized clinical trials software from Curebase
Curebase has named tenured clinical research expert Jane Myles as vice president of clinical trial innovation
Curebase decentralized clinical trial model will be used to study effectiveness in infections disease study
Curebase is promoting the concept of 'bring-your-own-physician' clinical trials.
Industry veteran, Paul Donnelly, brings more than two decades of success building healthcare companies to Curebase
Curebase featured in Wall Street Journal among startups realizing venture capital boom in digital health
Curebase decentralized trials platform used to study efficacy of diagnostic test
Curebase has raised a $15 million series A for a new approach to decentralized trials that goes beyond the current drop of virtual trial platforms.
Curebase is participating as a CRO partner with Cofactor Genomics in first multicenter clinical trial of its OncoPrism immunotherapy response prediction assay
Operationalizing drive-through COVID testing locations as clinical research sites provided a safe and convenient way to enroll and consent potential participants in key diagnostic validation study
CLM drug and DTx digital therapeutics study with Curebase
Digital interventions delivered through smartphones offer a promising alternative to traditional methods, but little is known about their effectiveness.
Curebase launches the CURE-19 Platform to provide a resource for researchers seeking to better understand COVID-19 as the pandemic begins
Interested in staying up to date with Curebase's latest developments in the decentralized clinical trial space? Get regular updates on news, webinars, blogs and more by subscribing here.
.png)
.png)
